• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌的组织病理学与手术分析:单中心两年经验

A Histopathological and Surgical Analysis of Gastric Cancer: A Two-Year Experience in a Single Center.

作者信息

Prodan-Bărbulescu Cătălin, Faur Flaviu Ionuț, Varga Norberth-Istvan, Hajjar Rami, Pașca Paul, Ghenciu Laura-Andreea, Feier Cătălin Ionuț Vlăduț, Dema Alis, Fărcuț Naomi, Bolintineanu Sorin, Dobrescu Amadeus, Duță Ciprian, Brebu Dan

机构信息

Department I, Discipline of Anatomy and Embriology, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

2nd Surgery Clinic, Timisoara Emergency County Hospital, 300723 Timisoara, Romania.

出版信息

Cancers (Basel). 2025 Jul 2;17(13):2219. doi: 10.3390/cancers17132219.

DOI:10.3390/cancers17132219
PMID:40647518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12248514/
Abstract

Gastric neoplasms remain pathologies of the malignant spectrum with high incidence and prevalence, with their management requiring a precise histopathological characterization for optimal treatment planning. The present study is a retrospective analysis that included 67 histopathologically confirmed gastric neoplasia subjects and was performed at a single surgical center from January 2020 to December 2021. Demographics, tumor characteristics, surgical procedures, and oncologic outcomes were included, filtered, and subsequently analyzed using SPSS Statistics 29.0. : This study involved 67 patients (mean age 65.7 years, 56.7% men), with adenocarcinoma being the most common histologic type (91.0%) and most tumors being diagnosed directly as Stage III (40.3%). Lauren classification revealed the intestinal type as the most common (49.2%), followed by diffuse (36.1%) and mixed (14.8%). Poorly differentiated tumors (G3) accounted for 53.7% of cases. The surgical team performed curative resection in 75% (n = 50) of patients, achieving R0 margins in 88% of these cases. Subtotal gastrectomy with D2 lymphadenectomy yielded the highest curative success rate with 96.6% R0 resection. Statistically, we identified two significant correlations between age and tumor grade (rho = 0.28; = 0.021) and between the number of lymph nodes examined and the number of lymph nodes invaded (rho = 0.65, < 0.001). This study again revealed that adenocarcinomas showed higher rates of lymph node invasion than other tumor types ( = 0.017). : The analysis of patients with gastric neoplasms is vital for appropriate therapeutic management. Even though the study period included a pandemic, the analysis remained a complex one with high-quality surgical outcomes, confirming the importance of maintaining oncologic standards during medical crises.

摘要

胃肿瘤仍然是恶性疾病谱中的高发病率和高患病率病症,其治疗需要精确的组织病理学特征来制定最佳治疗方案。本研究是一项回顾性分析,纳入了67例经组织病理学确诊的胃肿瘤患者,研究于2020年1月至2021年12月在单一外科中心进行。纳入了人口统计学、肿瘤特征、手术方式和肿瘤学结局等信息,进行筛选后,使用SPSS Statistics 29.0进行分析。本研究涉及67例患者(平均年龄65.7岁,男性占56.7%),腺癌是最常见的组织学类型(91.0%),大多数肿瘤直接诊断为III期(40.3%)。劳伦分类显示肠型最为常见(49.2%),其次是弥漫型(36.1%)和混合型(14.8%)。低分化肿瘤(G3)占病例的53.7%。手术团队对75%(n = 50)的患者进行了根治性切除,其中88%的病例实现了R0切缘。D2淋巴结清扫的胃次全切除术的根治成功率最高,R0切除率为96.6%。从统计学角度,我们发现年龄与肿瘤分级之间存在两个显著相关性(rho = 0.28;P = 0.021),以及检查的淋巴结数量与侵袭的淋巴结数量之间存在显著相关性(rho = 0.65,P < 0.001)。本研究再次表明,腺癌的淋巴结侵袭率高于其他肿瘤类型(P = 0.017)。对胃肿瘤患者的分析对于恰当的治疗管理至关重要。尽管研究期间包括一场大流行,但该分析仍是一项具有高质量手术结局的复杂分析,证实了在医疗危机期间维持肿瘤学标准的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/7490408abbf6/cancers-17-02219-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/0d3736400514/cancers-17-02219-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/91dc803b9be9/cancers-17-02219-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/adf7eaa5b31b/cancers-17-02219-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/e4044075cbb2/cancers-17-02219-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/02080cc6fc04/cancers-17-02219-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/002dbbb4fb52/cancers-17-02219-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/965bc6c2f6a5/cancers-17-02219-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/a6b8e5577195/cancers-17-02219-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/d01df2739a3a/cancers-17-02219-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/c5850d22ddce/cancers-17-02219-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/014773a5541c/cancers-17-02219-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/7490408abbf6/cancers-17-02219-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/0d3736400514/cancers-17-02219-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/91dc803b9be9/cancers-17-02219-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/adf7eaa5b31b/cancers-17-02219-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/e4044075cbb2/cancers-17-02219-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/02080cc6fc04/cancers-17-02219-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/002dbbb4fb52/cancers-17-02219-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/965bc6c2f6a5/cancers-17-02219-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/a6b8e5577195/cancers-17-02219-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/d01df2739a3a/cancers-17-02219-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/c5850d22ddce/cancers-17-02219-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/014773a5541c/cancers-17-02219-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cdc/12248514/7490408abbf6/cancers-17-02219-g012.jpg

相似文献

1
A Histopathological and Surgical Analysis of Gastric Cancer: A Two-Year Experience in a Single Center.胃癌的组织病理学与手术分析:单中心两年经验
Cancers (Basel). 2025 Jul 2;17(13):2219. doi: 10.3390/cancers17132219.
2
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Sexual Harassment and Prevention Training性骚扰与预防培训
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
6
[Application research of endoscopic-laparoscopic regional gastric resection combined with sentinel lymph node basin dissection in patients with early gastric cancer].内镜-腹腔镜区域胃切除术联合前哨淋巴结清扫在早期胃癌患者中的应用研究
Zhonghua Wai Ke Za Zhi. 2025 Jul 1;63(7):587-596. doi: 10.3760/cma.j.cn112139-20250117-00034.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
9
Two-Stage Gastrectomy Improves Outcomes in Perforated Gastric Cancer: A Single-Institution Retrospective Study.两阶段胃切除术改善穿孔性胃癌的预后:一项单机构回顾性研究
Cureus. 2025 May 28;17(5):e85002. doi: 10.7759/cureus.85002. eCollection 2025 May.
10
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.

引用本文的文献

1
A Comprehensive Review of the Latest Approaches to Managing Hypercholesterolemia: A Comparative Analysis of Conventional and Novel Treatments: Part I.高胆固醇血症管理最新方法的全面综述:传统治疗与新型治疗的比较分析:第一部分
Life (Basel). 2025 Jul 25;15(8):1185. doi: 10.3390/life15081185.

本文引用的文献

1
D2 Lymphadenectomy for Gastric Cancer: Advancements and Technical Considerations.胃癌的D2淋巴结清扫术:进展与技术考量
Ann Surg Oncol. 2025 Mar;32(3):2129-2140. doi: 10.1245/s10434-024-16545-6. Epub 2024 Nov 26.
2
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study.术前化疗后复发风险高(ypN+和/或R1)的胃及食管胃交界癌切除术后患者的辅助免疫治疗:欧洲癌症研究与治疗组织(EORTC)1707 VESTIGE研究
Ann Oncol. 2025 Feb;36(2):197-207. doi: 10.1016/j.annonc.2024.10.829. Epub 2024 Nov 13.
3
Theodor Billroth: The Pioneer Gastrectomy Surgeon and His Contributions to the Evolution of General Surgery.
西奥多·比尔罗特:胃切除术先驱外科医生及其对普通外科发展的贡献。
Cureus. 2024 Sep 7;16(9):e68861. doi: 10.7759/cureus.68861. eCollection 2024 Sep.
4
Global incidence and mortality trends of gastric cancer and predicted mortality of gastric cancer by 2035.全球胃癌发病率和死亡率趋势以及到 2035 年预测的胃癌死亡率。
BMC Public Health. 2024 Jul 2;24(1):1763. doi: 10.1186/s12889-024-19104-6.
5
Global burden of depression or depressive symptoms in children and adolescents: A systematic review and meta-analysis.儿童和青少年抑郁症或抑郁症状的全球负担:一项系统评价和荟萃分析。
J Affect Disord. 2024 Jun 1;354:553-562. doi: 10.1016/j.jad.2024.03.074. Epub 2024 Mar 14.
6
Burden of Stomach Cancer Incidence, Mortality, Disability-Adjusted Life Years, and Risk Factors in 204 Countries, 1990-2019: An Examination of Global Burden of Disease 2019.204 个国家 1990-2019 年胃癌发病、死亡、伤残调整生命年及危险因素负担:2019 年全球疾病负担研究
J Gastrointest Cancer. 2024 Jun;55(2):787-799. doi: 10.1007/s12029-023-01005-3. Epub 2024 Jan 24.
7
Updated Adjuvant Chemotherapy for Gastric Cancer.更新后的胃癌辅助化疗
J Clin Med. 2023 Oct 24;12(21):6727. doi: 10.3390/jcm12216727.
8
Current standards of lymphadenectomy in gastric cancer.胃癌淋巴结清扫的现状。
Updates Surg. 2023 Oct;75(7):1751-1758. doi: 10.1007/s13304-023-01576-7. Epub 2023 Jun 26.
9
Impact of positive microscopic resection margins (R1) after gastrectomy in diffuse-type gastric cancer.胃弥漫型癌胃切除术后阳性显微镜切缘(R1)的影响。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11105-11115. doi: 10.1007/s00432-023-04981-y. Epub 2023 Jun 21.
10
Gastric cancer treatment: recent progress and future perspectives.胃癌治疗:最新进展与未来展望。
J Hematol Oncol. 2023 May 27;16(1):57. doi: 10.1186/s13045-023-01451-3.